|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,520.00 JPY | -0.76% |
|
-2.51% | +3.36% |
| Capitalization | 14,129B 88.45B 75.56B 69.67B 65.75B 122B 8,282B 125B 816B 321B 3,955B 332B 325B | P/E ratio 2026 * |
27.9x | P/E ratio 2027 * | 24.5x |
|---|---|---|---|---|---|
| Enterprise value | 13,135B 82.23B 70.25B 64.77B 61.13B 114B 7,700B 116B 759B 298B 3,677B 309B 302B | EV / Sales 2026 * |
9.55x | EV / Sales 2027 * | 8.59x |
| Free-Float |
38.09% | Yield 2026 * |
1.59% | Yield 2027 * | 1.77% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -0.76% | ||
| 1 week | -2.51% | ||
| Current month | -1.06% | ||
| 1 month | -6.55% | ||
| 3 months | -0.09% | ||
| 6 months | +21.71% | ||
| Current year | +3.36% |
| 1 week | 8,425 |  | 9,080 |
| 1 month | 7,946 | | 9,459 |
| Current year | 7,946 | | 10,700 |
| 1 year | 5,942 | | 10,700 |
| 3 years | 3,241 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 01/01/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 28/03/2024 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Motoo Ueno
BRD | Director/Board Member | 68 | 01/03/1993 |
Masayuki Oku
BRD | Director/Board Member | 81 | 01/03/2015 |
| Director/Board Member | 77 | 01/03/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +8.06% | 6.57% | 29 M€ | |
| +9.82% | 1.87% | 69 M€ | |
| +8.01% | 1.59% | 4 M€ | |
| +15.60% | 1.53% | 73,790 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.76% | -2.51% | +29.05% | +155.01% | 88.45B | |
| -1.06% | +0.27% | +26.92% | +147.78% | 832B | |
| -0.21% | -1.25% | +56.83% | +43.25% | 573B | |
| -0.71% | -0.11% | +17.95% | +26.91% | 365B | |
| +0.49% | -0.75% | +29.45% | +14.12% | 322B | |
| -0.11% | +0.04% | +45.00% | +25.83% | 313B | |
| -1.05% | -0.58% | +51.74% | +3.95% | 297B | |
| +0.02% | +0.75% | +36.02% | +38.02% | 292B | |
| -0.34% | +2.12% | +22.32% | +39.13% | 189B | |
| +0.03% | -0.78% | +34.16% | +66.96% | 173B | |
| Average | -0.25% | -0.90% | +34.94% | +56.10% | 344.34B | |
| Weighted average by Cap. | -0.18% | -0.72% | +35.90% | +62.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,375B 8.61B 7.36B 6.78B 6.4B 11.89B 806B 12.2B 79.44B 31.23B 385B 32.31B 31.63B | 1,500B 9.39B 8.02B 7.4B 6.98B 12.97B 879B 13.3B 86.62B 34.05B 420B 35.23B 34.49B |
| Net income | 506B 3.17B 2.71B 2.49B 2.35B 4.37B 297B 4.49B 29.21B 11.49B 142B 11.88B 11.63B | 577B 3.61B 3.09B 2.85B 2.69B 4.99B 338B 5.12B 33.35B 13.11B 162B 13.57B 13.28B |
| Net Debt | -994B -6.22B -5.31B -4.9B -4.62B -8.59B -582B -8.81B -57.39B -22.56B -278B -23.34B -22.85B | -1,253B -7.85B -6.7B -6.18B -5.83B -10.84B -735B -11.11B -72.39B -28.46B -351B -29.45B -28.82B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/04/26 | 8,520.00 ¥ | -0.76% | 1,975,400 |
| 13/04/26 | 8,585.00 ¥ | -1.04% | 1,432,700 |
| 10/04/26 | 8,675.00 ¥ | -1.14% | 2,506,100 |
| 09/04/26 | 8,775.00 ¥ | -1.22% | 1,911,600 |
| 08/04/26 | 8,883.00 ¥ | +1.65% | 2,898,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition